FDA warns J&J on illegal marketing of medical devices
Another day, another Johnson & Johnson news item -- and once again, not a flattering one. The drugmaker, which can't seem to get its act straight lately, last week received a warning letter from the U.S. Food and Drug Administration that it is illegally marketing two products. In a letter to J&J's DePuy Orthopaedics, the FDA says it has learned that the company is marketing the TruMatch without the required marketing clearance or approval and in violation of the Federal Food, Drug, and Cosmetic Act. TruMatch Personalized Solutions System is a high-tech CT scanner that can create detailed 3-D views of a patient's knee for implant surgery. The regulatory authority, which recently began a crackdown on medical devices, asked the company to submit information to gain marketing approval. "The FDA will evaluate the information you submit and decide whether your product may be legally marketed," the letter stated.
- CMS Reveals Central Line Infection Rates, Finally
- Keeping Readmission Rates Low with Treatment Guidelines
- 5010 Logjam Means No Pay for Physicians
- Medicare Physician Payment Rule Factors in GPCI
- Leading Change is Tough from the Back of a Limo
- Feds Release Final Rules on Health Plan Language
- Getting to the Heart of Cardiology Alignment
- Engineering a High-Performance Emergency Department
- UnitedHealth will tie doctors' payments to quality of care
- Parkland Keeping Consultant's Analysis Under Wraps

